#NEJM

Ethan Weiss

ethanjweiss

Simply wowOnce-Weekly Semaglutide in Adults with Overweight or Obesity | NEJMhttps://www.nejm.org/doi/full/10.1056/NEJMoa2032183#.YCRhRVYGIoM.twitter This is pretty freaking remarkable It is not surprising that there were some significant G

Jim Al-Khalili

jimalkhalili

1/6 We need clear, transparent information on issue of delaying the 2nd Pfizer jab from 3 weeks to 12 weeks. Pfizer don't know if this is a good idea because

Diego Bassani, PhD 🏠😷

DGBassani

SARS-CoV-2 Transmission among Marine Recruits during Quarantine | NEJMhttps://www.nejm.org/doi/full/10.1056/NEJMoa2029717#.X6yTHiwpVmM.twitter This study uses molecular phylogenetic analysis to confirm that the infections happened within th

Eric Topol

EricTopol

Here's how New Zealand eliminated #COVID19new @NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2025203?query=featured_home The pandemic only lasted 103 in New Zealand and it has now gone 100 days since without a single new case.This par

Tim Coorens

TimCoorens

Our latest paper is out today in NEJM! Together with Sam Behjati, I explored the origins of bilateral neuroblastoma from somatic mutations. [1/6]https://www.nejm.org/doi/full/10.1056/NEJMoa2000962 Neuroblastoma is a common childhood cancer

Michelle Rheault

rheault_m

In 2016, NIDDK put out a request for proposals for clinical trials looking at the effect of lowering uric acid on progression of children with CKD. I put together the

Louis-Alexandre Alciator

AlciatorLA

Première étude disponible sur le vaccin Pfizer.https://www.nejm.org/action/doSecureKeyLogin?uri=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2034577%3Fquery%3DRP&uuid=11698682&dateTime=202012200000&key=BXcfdgqC5jT

Marina Medvin 🇺🇸

MarinaMedvin

"There is insufficient evidence to support the claim that masks reduce the infectious dose of SARS-CoV-2 and the severity of Covid-19... suggestion that masks offer an alternative ... implicitly encourages

Stephen V Liu

StephenVLiu

#OncoAlert Available @NEJM, results from the phase III CROWN trial of lorlatinib versus crizotinib as first line treatment for #ALK NSCLC. Initially presented at virtual #ESMO20, lorlatinib had a significantly

Dr Shalini Arunogiri

SArunogiri

Bupropion and Naltrexone in Methamphetamine Use Disorder | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2020214#.YACoDTr9HmI.twitter Results of the multisite ADAPT-2 trial just published in @NEJM - 11% effect, NNT 9Here's my thread

LKSOM Medicine Clerkship

LKSOM_Medicine

Today's #WildcardWednesday discussion is inspired by this week’s “Annals On Call” podcast episode about COVID-19 vaccine hesitancy. It’s a great 25 minute conversation between @gradydoctor and @medrants. We definitely recommend

David

PrimaryCarePAC

There is a lot of “may do” this and that with kidneys and protein. What’s been demonstrated.Here is one (there are more). Low protein (1.3g/kg vs 0.58) in those with

D-Money 🇹🇹

nerdclapback

1/Just finished reading the NEJM paper on the Pfizer mRNA vaccine. I've always maintained that seeing clinical trial data published in a peer reviewed journal of significance would be my

The Unsilent Majority

TheUnsilentMaj3

1. China never isolated the virus. They cloned RNA from lung fluid.2. PCRs do not diagnose specific viruses. 3. “Cases” are just PCRs run at cycles high enough to magnify

Andrew💙Croxford

andrew_croxford

COMMENT: I was startled by the decision to delay the second dose of the Pfizer vaccine, mentioned at today’s morning presser which focused mainly on the Astra/Ox vaccine. In the

David Juurlink

DavidJuurlink

So, which doctors should you believe about the effectiveness of hydroxychloroquine?The ones whose views derive from RCTs. It really is as simple as that.And what do RCTs tell us?/12 After

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.